R. Andrew Ramelmeier
Overview
R. Andrew Ramelmeier received an average of $1M in total compensation, including $405K in salary, at Sangamo Biosciences from 2019 to 2021.
Source: SEC filings on April 1, 2022, April 2, 2021, and April 1, 2020.
Related executives
We found 18 more executives who work or worked at Sangamo Biosciences.
Alexander Macrae
Sangamo Biosciences
Chief Executive Officer
Robert Schott
Sangamo Biosciences
Senior Vice President, Head of Development
D McClung
Sangamo Biosciences
Chief Operating Officer
Prathyusha Duraibabu
Sangamo Biosciences
Chief Financial Officer
Sung Lee
Sangamo Biosciences
Chief Financial Officer
Stéphane Boissel
Sangamo Biosciences
Former Executive Vice President, Corporate Strategy
Gary Loeb
Sangamo Biosciences
General Counsel
Adrian Woolfson
Sangamo Biosciences